{"name":"Andrew B Adams","slug":"andrew-b-adams","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Calcineurin inhibitor therapy","genericName":"Calcineurin inhibitor therapy","slug":"calcineurin-inhibitor-therapy","indication":"Organ transplant rejection prophylaxis","status":"phase_3"}]}],"pipeline":[{"name":"Calcineurin inhibitor therapy","genericName":"Calcineurin inhibitor therapy","slug":"calcineurin-inhibitor-therapy","phase":"phase_3","mechanism":"Calcineurin inhibitors suppress T-cell activation by blocking the phosphatase calcineurin, preventing the dephosphorylation and nuclear translocation of NFAT transcription factors required for cytokine production.","indications":["Organ transplant rejection prophylaxis","Autoimmune and inflammatory disorders"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQR0N4X3hlRVdBbWxuV0tpaVVvT0lSQnVVWmxjeFUzNEJZV21wTXVhVFh4TTZreFNvaElnQTBENy10aDVWT0N0bVM4ekZ5c012eUlxLXdWeGU0Qm9ZaHRNbU9uRW9uOGtnQXNxcFpsaXlFaG9vdG5QQ29pQ0tYYVlEUUgwa3dYTjVuaGIzaGRZSmRiTUxhWHhqRHlXSzFNWjVXYUs2bDI0SEk2SHpOMkxYZlFLU19peHNZVVRVOGd1M1U0UQ?oc=5","date":"2025-03-13","type":"regulatory","source":"The Macdonald-Laurier Institute","summary":"Life on hold - How Canada’s drug approval delays endanger patients: Nigel S.B. Rawson and John Adams - The Macdonald-Laurier Institute","headline":"Life on hold - How Canada’s drug approval delays endanger patients: Nigel S.B. Rawson and John Adams - The Macdonald","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE9Wdkw1SkxTV0VxN09ETHRnWHE2OE5vekx0Y0J5LTgyQlNNN2hjcV84R0dnVWF1LV9XWTg0WFpuYnRtejU2UzNHZTFueU0xV3pFRldVTTBKT0JHSWxvNklDaXFaQXMtQkhYeElvZWlqeFYxd21r?oc=5","date":"2024-05-15","type":"pipeline","source":"University of Louisiana at Monroe","summary":"Degrees awarded to 936 graduates at ULM Spring 2024 commencement ceremonies - University of Louisiana at Monroe","headline":"Degrees awarded to 936 graduates at ULM Spring 2024 commencement ceremonies","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}